Autoantibodies are frequently found in arterial and chronic thrombotic pulmonary hypertension not associated to connective tissue diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Ortner‘s syndrome associated with secondary pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 55s Year: 2004
Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease Source: ERJ Open Res, 6 (4) 00297-2019; 10.1183/23120541.00297-2019 Year: 2020
Portopulmonary hypertension: a further clue to pathogenesis? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005
Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004
Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007
Women: lung and autoimmune disease Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=190 Year: 2003
Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019
Pulmonary arterial hypertension in connective tissue diseases Source: Eur Respir Mon 2012; 57: 42-57 Year: 2012
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1800467; 10.1183/13993003.00467-2018 Year: 2018
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020
Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
The metabolic syndrome and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020
Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016
D-dimers in patients with chronic obstructive pulmonary disease with or without secondary secondary erythrocytosis Source: Eur Respir J 2004; 24: Suppl. 48, 14s Year: 2004
Four year experience of a dedicated connective tissue disorder pulmonary hypertension clinic Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009
Features of pulmonary involvement in patients with diffuse connective tissue diseases Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Pulmonary hypertension in collagen vascular disease Source: Eur Respir J 2002; 19: 571-576 Year: 2002